Amanpreet, Arshdeep Kaur Chann, Dixa, Jyoti, Misha Kataria, Kavita, Monika Pebma, J. S Thakur
Amanpreet1, Arshdeep Kaur Chann1, Dixa1, Jyoti1, Misha Kataria1, Kavita2, Monika Pebma3, J. S Thakur4
1B.Sc Nursing Intern, National Institute of Nursing Education, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
2Lecturer, National Institute of Nursing Education, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
3Tutor, National Institute of Nursing Education, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
4Professor, Department of Community Medicine and School of Public Health, PGIMER, Chandigarh, India.
Volume - 12,
Issue - 2,
Year - 2022
Introduction: Covid-19 is a respiratory disease caused by severe acute respiratory disease syndrome Coronavirus 2(sars-cov-2). Health outcomes varies broadly in patients with and without comorbidities. Objectives: The purpose of the study was to assess the prevalence of comorbidities and health outcomes among Covid-19 patients residing in Indira colony, Chandigarh. Method: A descriptive cross-sectional study was conducted to enroll all Covid-19 patients over a period of two weeks. The list of patients was obtained from ANM’s of the selected area. A semi structured interview schedule was developed to collect information telephonically and responses were recorded on Google forms. Result: A total of 110 participants were enrolled in the study. The results revealed that 81% of participants were having Covid-19 symptoms. Fever was the most common symptom (88.8%) A total of 25 patient (22.7%) person having comorbidities diabetes mellitus was the most common comorbidity (44%) seen in participants. About 27.2% of the total patients required hospitalization. Only few participants required mechanical ventilation. Zero deaths were reported in the present study. Conclusion: Fever was the most common symptom in symptomatic patients followed by cough. The most prevalent comorbidity in patient was diabetes mellitus and there was no fatality seen in studied population.
Cite this article:
Amanpreet, Arshdeep Kaur Chann, Dixa, Jyoti, Misha Kataria, Kavita, Monika Pebma, J. S Thakur. Health outcomes and comorbidities among Covid-19 patients from a Peri urban community of Chandigarh. Asian Journal of Nursing Education and Research. 2022; 12(2):235-8. doi: 10.52711/2349-2996.2022.00048
Amanpreet, Arshdeep Kaur Chann, Dixa, Jyoti, Misha Kataria, Kavita, Monika Pebma, J. S Thakur. Health outcomes and comorbidities among Covid-19 patients from a Peri urban community of Chandigarh. Asian Journal of Nursing Education and Research. 2022; 12(2):235-8. doi: 10.52711/2349-2996.2022.00048 Available on: https://ajner.com/AbstractView.aspx?PID=2022-12-2-17
1. World Health Organization. Coronavirus disease (COVID-19) Situation Report-41 [Internet]. Geneva, switzerland; 2020 [cited 2021 Apr 6]. Available from: https://openwho.org/courses/severe-acute-respiratory-infection.
2. CDC. Coronavirus (COVID-19): symptoms of coronavirus. Centers for Disease Control and Prevention. 2020. [Accessed https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html].
3. Luo L, Fu M, Li Y, Hu S, Luo J, Chen Z, et al. The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: a pooled analysis. Clin Cardiol. 2020;43(12):1478–93
4. Sanyaolu, A., Okorie, C., Marinkovic, A., Patidar, R., Younis, K., Desai, P., ... and Altaf, M. (2020). Comorbidity and its impact on patients with COVID-19. SN comprehensive clinical medicine, 1-8.
5. Kreidl P, Schmid D, Maritschnik S, Richter, L., Borena, W., Genger, J. et al. Emergence of coronavirus disease 2019 (COVID-19) in Austria. Wien Klin Wochenschr. 2020;132(21-22):645-652. doi:10.1007/s00508-020-01723-9
6. https://www.mohfw.gov.in/pdf/ RevisedguidelinesforHomeIsolationofverymildpresymptomatic COVID19cases10May2020.pdf
7. Lee HW, Yoon SY, Lee JK, Park TY, Kim DK, Chung HS, et al. Clinical implication and risk factor of pneumonia development in mild coronavirus disease 2019 patients. Korean J Intern Med. 2021;36(1):1–10. https://doi.org/10.3904/kjim.2020.329
8. AlJishi JM, Alhajjaj AH, Alkhabbaz FL, AlAbduljabar TH, Alsaif A, Alsaif H et al . Clinical characteristics of asymptomatic and symptomatic COVID-19 patients in the Eastern Province of Saudi Arabia. J Infect Public Health. 2021 Jan;14(1):6-11. doi: 10.1016/j.jiph.2020.11.002. Epub 2020 Dec 17. PMID: 33341486; PMCID: PMC7744936.
9. Paudel SS. A meta-analysis of 2019 novel coronavirus patient clinical characteristics and comorbidities. Research Square. 2020. https://doi.org/10.21203/rs.3.rs-21831/v1 [Accessed April 11, 2021, https://www.researchsquare.com/article/rs-21831/v1].
10. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775. Erratum in: JAMA. 2020 May 26;323(20):2098. PMID: 32320003; PMCID: PMC7177629.
11. Pongpirul WA, Wiboonchutikul S, Charoenpong L, Panitantum N, Vachiraphan A, Uttayamakul S, et al. Clinical course and potential predictive factors for pneumonia of adult patients with Coronavirus Disease 2019 (COVID-19): a retrospective observational analysis of 193 confirmed cases in Thailand. PLoS Negl Trop Dis. 2020;14(10):e0008806. https://doi.org/10. 1371/journal.pntd.0008806
12. Puah SH, Young BE, Chia PY, Ho VK, Loh J, Gokhale RS, et al. Clinical features and predictors of severity in COVID-19 patients with critical illness in Singapore. Sci Rep. 2021;11(1):7477. https://doi.org/10.1038/s41598-021-81377-3
13. Osibogun A, Balogun M, Abayomi A, Idris J, Kuyinu Y, Odukoya O, et al. (2021) Outcomes of COVID-19 patients with comorbidities in southwest Nigeria. PLoS ONE 16(3): e0248281. https://doi.org/10.1371/journal.pone.0248281
14. Li Y, Shi J, Xia J, Duan J, Chen L, Yu X, et al. Asymptomatic and symptomatic patients with non-severe coronavirus disease (COVID-19) have similar clinical features and virological courses: a retrospective single center study. Front Microbiol. 2020. https://doi.org/10.3389/fmicb.2020.01570
15. Liu X-Q, Xue S, Xu J-B, Ge H, Mao Q, Xu X-H, et al. Clinical characteristics and related risk factors of disease severity in 101 COVID-19 patients hospitalized in Wuhan, China. Acta Pharmacol Sin. 2021. https://doi.org/ 10.1038/s41401-021-00627-2